Roche’s Virtual Early Drug Development gRED Event 2020
Roche has hosted a live video webcast on Tuesday, 18 February 2020.
| Agenda | |
|---|---|
| Welcome | Karl Mahler, Head of Investor Relations and Roche Group Planning |
| Overview and Introduction to Genentech (gRED) | Michael Varney, Head of Genentech Research and Early Development |
| Oncology Pipeline Overview | Stuart Lutzker, Vice President, Oncology Research and ad interim Head of Early Clinical Development for gRED |
| Cancer Immunotherapy | Ira Mellman, Vice President, Cancer Immunology and Immunology for gRED |
| Q&A |
Please register to access the replay* *Privacy notice